Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sercan Aksoy

Showing results (131-140 of 206) with videos related to

Pageof 21
Sort By:
Journal of Clinical Medicine|March 17, 2025
Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with CancerOnur Baş, Naciye Güdük, Mert Tokatlı, et al.
Cancers|March 29, 2023
Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology GroupIzzet Dogan, Sercan Aksoy, Burcu Cakar, et al.
Journal of Cancer Research and Clinical Oncology|August 12, 2022
The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort studyDeniz Can Guven, Emre Yekeduz, Enes Erul, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancerOzturk Ates, Taner Babacan, Neyran Kertmen, et al.
BMC Cancer|October 1, 2025
Real-world treatment patterns and survival outcomes in metastatic head and neck adenoid cystic carcinomaHatice Bölek, Mehmet Kayaalp, Taha Koray Şahin, et al.
Future Oncology (London, England)|November 11, 2021
Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experienceOmer Diker, Burak Yasin Aktas, Recep Ak, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 2, 2023
Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancerGörkem Yazıcı Şener, Osman Sütcüoğlu, Betül Öğüt, et al.
Anticancer Research|February 11, 2015
Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in ratsNeyran Kertmen, Sercan Aksoy, Aysegul Uner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 28, 2020
Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitorsDeniz Can Guven, Taha Koray Sahin, Melek Seren Aksun, et al.
Urologic Oncology|August 7, 2012
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapyMuhammet Fuat Ozcan, Omer Dizdar, Nazmiye Dincer, et al.
Pageof 21

Showing results (131-140 of 206) with videos related to

Sort By:
Pageof 21
Journal of Clinical Medicine|March 17, 2025
Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with CancerOnur Baş, Naciye Güdük, Mert Tokatlı, et al.
Cancers|March 29, 2023
Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology GroupIzzet Dogan, Sercan Aksoy, Burcu Cakar, et al.
Journal of Cancer Research and Clinical Oncology|August 12, 2022
The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort studyDeniz Can Guven, Emre Yekeduz, Enes Erul, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancerOzturk Ates, Taner Babacan, Neyran Kertmen, et al.
BMC Cancer|October 1, 2025
Real-world treatment patterns and survival outcomes in metastatic head and neck adenoid cystic carcinomaHatice Bölek, Mehmet Kayaalp, Taha Koray Şahin, et al.
Future Oncology (London, England)|November 11, 2021
Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experienceOmer Diker, Burak Yasin Aktas, Recep Ak, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 2, 2023
Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancerGörkem Yazıcı Şener, Osman Sütcüoğlu, Betül Öğüt, et al.
Anticancer Research|February 11, 2015
Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in ratsNeyran Kertmen, Sercan Aksoy, Aysegul Uner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 28, 2020
Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitorsDeniz Can Guven, Taha Koray Sahin, Melek Seren Aksun, et al.
Urologic Oncology|August 7, 2012
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapyMuhammet Fuat Ozcan, Omer Dizdar, Nazmiye Dincer, et al.
Pageof 21